These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 14691053)
1. Oleamide: a member of the endocannabinoid family? Fowler CJ Br J Pharmacol; 2004 Jan; 141(2):195-6. PubMed ID: 14691053 [TBL] [Abstract][Full Text] [Related]
2. Oleamide: a fatty acid amide signaling molecule in the cardiovascular system? Hiley CR; Hoi PM Cardiovasc Drug Rev; 2007; 25(1):46-60. PubMed ID: 17445087 [TBL] [Abstract][Full Text] [Related]
3. Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension. Hopps JJ; Dunn WR; Randall MD Eur J Pharmacol; 2012 Jun; 684(1-3):102-7. PubMed ID: 22465182 [TBL] [Abstract][Full Text] [Related]
4. Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. Leggett JD; Aspley S; Beckett SR; D'Antona AM; Kendall DA; Kendall DA Br J Pharmacol; 2004 Jan; 141(2):253-62. PubMed ID: 14707029 [TBL] [Abstract][Full Text] [Related]
5. Tuning the endocannabinoid system: allosteric modulators of the CB1 receptor. Ross RA Br J Pharmacol; 2007 Nov; 152(5):565-6. PubMed ID: 17592508 [TBL] [Abstract][Full Text] [Related]
6. Update on the endocannabinoid system as an anticancer target. Malfitano AM; Ciaglia E; Gangemi G; Gazzerro P; Laezza C; Bifulco M Expert Opin Ther Targets; 2011 Mar; 15(3):297-308. PubMed ID: 21244344 [TBL] [Abstract][Full Text] [Related]
7. The palmitoylethanolamide and oleamide enigmas : are these two fatty acid amides cannabimimetic? Lambert DM; Di Marzo V Curr Med Chem; 1999 Aug; 6(8):757-73. PubMed ID: 10469890 [TBL] [Abstract][Full Text] [Related]
9. Oleamide and anandamide effects on food intake and sexual behavior of rats. Martínez-González D; Bonilla-Jaime H; Morales-Otal A; Henriksen SJ; Velázquez-Moctezuma J; Prospéro-García O Neurosci Lett; 2004 Jun; 364(1):1-6. PubMed ID: 15193744 [TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid system: a general view and latest additions. De Petrocellis L; Cascio MG; Di Marzo V Br J Pharmacol; 2004 Mar; 141(5):765-74. PubMed ID: 14744801 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of (13S)-methyl-substituted arachidonic acid analogues: templates for novel endocannabinoids. Papahatjis DP; Nahmias VR; Nikas SP; Schimpgen M; Makriyannis A Chemistry; 2010 Apr; 16(13):4091-9. PubMed ID: 20187040 [TBL] [Abstract][Full Text] [Related]
12. The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity. Heyman E; Gamelin FX; Aucouturier J; Di Marzo V Obes Rev; 2012 Dec; 13(12):1110-24. PubMed ID: 22943701 [TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid overactivity and intestinal inflammation. Di Marzo V; Izzo AA Gut; 2006 Oct; 55(10):1373-6. PubMed ID: 16966693 [TBL] [Abstract][Full Text] [Related]
14. The role of the CB1 receptor in the regulation of sleep. Murillo-Rodríguez E Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1420-7. PubMed ID: 18514375 [TBL] [Abstract][Full Text] [Related]
15. The sleep inducing factor oleamide is produced by mouse neuroblastoma cells. Bisogno T; Sepe N; De Petrocellis L; Mechoulam R; Di Marzo V Biochem Biophys Res Commun; 1997 Oct; 239(2):473-9. PubMed ID: 9344854 [TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction. Lafenêtre P; Chaouloff F; Marsicano G Pharmacol Res; 2007 Nov; 56(5):367-81. PubMed ID: 17951068 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of endocannabinoid signaling and the pharmacotherapy of depression. Mangieri RA; Piomelli D Pharmacol Res; 2007 Nov; 56(5):360-6. PubMed ID: 17945507 [TBL] [Abstract][Full Text] [Related]
18. Manipulation of the endocannabinoid system by a general anaesthetic. Di Marzo V Br J Pharmacol; 2003 Jul; 139(5):885-6. PubMed ID: 12839861 [TBL] [Abstract][Full Text] [Related]